Back to Search Start Over

Risk-treatment mismatch in the pharmacotherapy of heart failure

Authors :
Douglas S. Lee
Juurlink, David N.
Dennis T. Ko
Alice Chong
Stukel, Therese A.
Jack V. Tu
Alter, David A.
Austin, Peter C.
Levy, Daniel
Laupacis, Andreas
Source :
JAMA, The Journal of the American Medical Association. Sept 14, 2005, Vol. 294 Issue 10, p1240, 8 p.
Publication Year :
2005

Abstract

Patterns of drug therapy and underlying mortality risk in patients with heart failure were investigated. Findings reveal that patients with heart failure at greatest risk of death were least likely to receive angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs) and beta-adrenoreceptor antagonists.

Subjects

Subjects :
Cardiac patients -- Risk factors
Cardiac patients -- Drug therapy
ACE inhibitors -- Dosage and administration

Details

Language :
English
ISSN :
00987484
Volume :
294
Issue :
10
Database :
Gale General OneFile
Journal :
JAMA, The Journal of the American Medical Association
Publication Type :
Academic Journal
Accession number :
edsgcl.137843426

Tools

Authors Abstract Subjects Details